Hyam Levitsky

Johns Hopkins University, Baltimore, MD 
Biomedical Engineering, Radiology, Immunology
"Hyam Levitsky"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kadayakkara DK, Korrer MJ, Bulte JW, et al. (2015) Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging. Cancer Research. 75: 51-61
Ries CH, Cannarile MA, Hoves S, et al. (2014) Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell. 25: 846-59
Goswami M, Hensel N, Smith BD, et al. (2014) Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues. Leukemia. 28: 1167-70
Gnanakkan VP, Jaffe AE, Dai L, et al. (2013) TE-array--a high throughput tool to study transposon transcription. Bmc Genomics. 14: 869
Marabelle A, Kohrt H, Sagiv-Barfi I, et al. (2013) Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. The Journal of Clinical Investigation. 123: 2447-63
Qin L, Smith BD, Tsai HL, et al. (2013) Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy Blood Cancer Journal. 3
Britten CM, Janetzki S, Butterfield LH, et al. (2012) T cell assays and MIATA: the essential minimum for maximum impact. Immunity. 37: 1-2
Zhou G, Levitsky H. (2012) Towards curative cancer immunotherapy: overcoming posttherapy tumor escape. Clinical & Developmental Immunology. 2012: 124187
Fox BA, Schendel DJ, Butterfield LH, et al. (2011) Defining the critical hurdles in cancer immunotherapy. Journal of Translational Medicine. 9: 214
Hourigan CS, Levitsky HI. (2011) Evaluation of current cancer immunotherapy: hemato-oncology. Cancer Journal (Sudbury, Mass.). 17: 309-24
See more...